RhoVac announces a rights issue of SEK 24.5 million aimed at strengthening business development activities
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. On 9 April 2018, the board of directors of RhoVac AB (publ) (“RhoVac” or “the Company”) resolved to propose the annual general meeting of 9 May 2018 to resolve on a rights issue of approximately SEK 24.5 million before issue costs. The net proceeds of the rights issue are primarily intended to strengthen the Company's position, thereby creating better conditions in the work of identifying potential